Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Assured Investment Management LLC	2. Issuer Name and Ticker or Trading Symbol AdaptHealth Corp. [ AHCO ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle) 280 PARK AVENUE, 12TH FLOOR	3. Date of Earliest Transaction (MM/DD/YYYY) 11/11/2020
(Street) NEW YORK, NY 10017 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock ⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾	11/12/2020		C		150581	A	⁽³⁾⁽⁴⁾	3797934	I	Footnotes ⁽¹⁾⁽²⁾⁽³⁾

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Class B Common Stock ⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾	⁽³⁾	11/11/2020		C			150581	11/8/2019	⁽³⁾	Class A Common Stock ⁽³⁾	⁽³⁾	$0.00	0	I	Footnotes ⁽¹⁾⁽²⁾⁽³⁾

Explanation of Responses:
(1)	The filing of this Form 4 shall not be construed as an admission that Assured Investment Management LLC (f/k/a BlueMountain Capital Management, LLC) ("AssuredIM") is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise the beneficial owner of any shares of Class A Common Stock, par value $0.0001 per share ("Class A Common Stock"), of AdaptHealth Corp. (the "Issuer") or Class B Common Stock, par value $0.0001 per share ("Class B Common Stock" and, together with the Class A Common Stock, the "Common Stock"), of the Issuer. Pursuant to Rule 16a-1(a)(4) of the Exchange Act, AssuredIM disclaims such beneficial ownership, except to the extent of its pecuniary interest.
(2)	AssuredIM is the investment manager of BlueMountain Summit Opportunities Fund II (US) L.P. (the "Fund"), which was the direct beneficial owner of 150,581 shares of Class B Common Stock and is the beneficial owner of 150,581 shares of Class A Common Stock. AssuredIM, although it directs the disposition and voting of the Common Stock held by the Fund, only receives an asset-based fee relating to the Common Stock.
(3)	Pursuant to the terms of the Exchange Agreement dated as of November 8, 2019 by and among the Issuer, AdaptHealth Holdings LLC, a subsidiary of the Issuer, and the other parties thereto (the "Exchange Agreement"), each share of Class B Common Stock, when combined with a common unit representing limited liability company interests in AdaptHealth Holdings LLC ("LLC Unit"), is exchangeable at any time for one share of Class A Common Stock or, at the Issuer's election, the cash equivalent to the market value of one share of Class A Common Stock. The Class B Common Stock has no expiration date.
(4)	On November 11, 2020, the Fund delivered notice to the Issuer for the conversion of 150,581 shares of Class B Common Stock and LLC Units pursuant to the terms of the Exchange Agreement. On November 12, 2020, in connection with such conversion, the Fund received 150,581 shares of Class A Common Stock from the Issuer.

Remarks:
Dale Wolf serves as a director of the Issuer as the representative of AssuredIM. In connection therewith, AssuredIM may be deemed to be a director by deputization of the Issuer solely for purposes of Section 16(a) of the Exchange Act. As a result, AssuredIM is listed as a "Reporting Person" in Item 1 and the "Director" box is marked in Item 4 of this Form 4.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Assured Investment Management LLC 280 PARK AVENUE, 12TH FLOOR NEW YORK, NY 10017	X

Signatures
Assured Investment Management LLC, By: /s/ Eric M. Albert, Chief Compliance Officer		11/13/2020
^**Signature of Reporting Person		Date